The current total economic burden of diabetes mellitus in the Netherlands.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Netherlands Journal of Medicine

• Publication date

  2017-09-01

• Fields of study

  Medicine, Economics

• Identifiers
  PMID 28956787
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Economic Costs of Type 2 Diabetes: A Global Systematic Review

  2015cited by this paper
• The global impact of non-communicable diseases on healthcare spending and national income: a systematic review

  2015cited by this paper
• Societal costs of diabetes mellitus in Denmark

  2015influential reference
• Refitting of the UKPDS 68 Risk Equations to Contemporary Routine Clinical Practice Data in the UK

  2015cited by this paper
• Adherence to diabetes medication: a systematic review

  2015cited by this paper
• Estimating the real world daily usage and cost for exenatide twice daily and liraglutide in Germany, the Netherlands, and the UK based on volumes dispensed by pharmacies

  2015cited by this paper
• Comorbiditeit bij diabetes type 2

  2014cited by this paper
• De frequentie en impact van niet-ernstige hypoglycemie bij insulinegebruik in Nederland

  2014cited by this paper
• Effectiveness and cost‐effectiveness of 3‐monthly versus 6‐monthly monitoring of well‐controlled type 2 diabetes patients: a pragmatic randomised controlled patient‐preference equivalence trial in primary care (EFFIMODI study)

  2014cited by this paper
• Cost Effectiveness of Adding Dapagliflozin to Insulin for the Treatment of Type 2 Diabetes Mellitus in the Netherlands

  2014cited by this paper
• Resource use and costs of type 2 diabetes patients receiving managed or protocolized primary care: a controlled clinical trial

  2014influential reference
• Nursing home patients with diabetes: prevalence, drug treatment and glycemic control.

  2014cited by this paper
• Diabetes associated with early labor-force exit: a comparison of sixteen high-income countries.

  2014cited by this paper
• Type II diabetes patients in primary care: profiles of healthcare utilization obtained from observational data

  2013cited by this paper
• Effects of patient-reported non-severe hypoglycemia on healthcare resource use, work-time loss, and wellbeing in insulin-treated patients with diabetes in seven European countries

  2013cited by this paper
• Using Spatial Analysis to Predict Health Care Use at the Local Level: A Case Study of Type 2 Diabetes Medication Use and Its Association with Demographic Change and Socioeconomic Status

  2013cited by this paper
• Understanding the economic burden of nonsevere nocturnal hypoglycemic events: impact on work productivity, disease management, and resource utilization.

  2013cited by this paper
• Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs

  2012cited by this paper
• Statin treatment for primary prevention of vascular disease: whom to treat? Cost-effectiveness analysis

  2011cited by this paper
• Cost-Effectiveness of Angiotensin-Converting Enzyme Inhibitors for the Prevention of Diabetic Nephropathy in The Netherlands – A Markov Model

  2011cited by this paper
• A trial-based economic evaluation of 2 nurse-led disease management programs in heart failure.

  2011cited by this paper
• What part of the total care consumed by type 2 diabetes patients is directly related to diabetes? Implications for disease management programs

  2011cited by this paper
• Long-Term Health and Work Outcomes of Renal Transplantation and Patterns of Work Status During the End-Stage Renal Disease Trajectory

  2011cited by this paper
• Atrial fibrillation: the cost of illness in Sweden

  2010cited by this paper
• Lifetime health effects and medical costs of integrated stroke services - a non-randomized controlled cluster-trial based life table approach

  2010cited by this paper
• Return to work after acute ST-segment elevation myocardial infarction in the modern era of reperfusion by direct percutaneous coronary intervention.

  2010cited by this paper
• [Diabetes mellitus in the Netherlands: estimate of the current disease burden and prognosis for 2025].

  2009cited by this paper
• Three-year efficacy of complex insulin regimens in type 2 diabetes.

  2009cited by this paper
• Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement

  2009cited by this paper
• Utility loss and indirect costs after stroke in Sweden

  2008cited by this paper
• Estimating the cost of complications of diabetes in Australia using administrative health-care data.

  2008cited by this paper
• Patient Perceptions of Quality of Life With Diabetes-Related Complications and Treatments

  2007influential reference
• Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration

  2007cited by this paper
• Return to work after lower limb amputation

  2007cited by this paper
• Costs of vision impairment: present and future issues

  2007cited by this paper
• Diabetes in Nederland. Omvang, risicofactoren en gevolgen, nu en in de toekomst

  2007cited by this paper
• Cost of hypoglycemia in patients with Type 2 diabetes in Sweden.

  2006cited by this paper
• Pathogenesis of type 2 diabetes mellitus.

  2004cited by this paper
• Lifetime health effects and costs of diabetes treatment.

  2003cited by this paper
• Return to work after lower limb amputation

  2003cited by this paper
• Impact of long-term complications on quality of life in patients with type 2 diabetes not using insulin.

  2001cited by this paper
• NHG-standaard Diabetes Mellitus type 2 (eerste herziening)

  1999cited by this paper
• Cost-of-Illness Studies

  1998cited by this paper
• International Textbook of Diabetes Mellitus

  1993influential reference
• Clinical characteristics and management of diabetic patients residing in a nursing home.

  1991cited by this paper
• Prevalentie van diabetes mellitus in verzorgingstehuizen

  1989cited by this paper
• Diabetes Mellitus in Elderly Nursing Home Patients A Survey of Clinical Characteristics and Management

  1988cited by this paper

• Clinical and sociodemographic factors of diabetes mellitus among people living with HIV in Ethiopia: a systematic review and meta-analysis.

  2026cites this paper
• Medical costs and health care utilization in Dutch diabetes patients with high levels of diabetes-distress.

  2025cites this paper
• A Novel 10-Year Value-Based Contract to Improve Type 1 Diabetes Care in the Netherlands

  2025cites this paper
• Automated Insulin Delivery Versus Standard of Care in the Management of People Living with Type 1 Diabetes and HbA1c <8%: A Cost–Utility Analysis in The Netherlands

  2025cites this paper
• Association between Metrnl and carotid atherosclerosis in patients with type 2 diabetes mellitus

  2025cites this paper
• Cost-effectiveness of Freestyle Libre Systems for People with Type 2 Diabetes Mellitus on Basal Insulin Therapy in the Netherlands: An Economic Evaluation from a Societal Perspective Within a Publicly Funded Healthcare System

  2025influential citation
• Real-World Use of Oral Semaglutide in Adults with Type 2 Diabetes in the PIONEER REAL Netherlands Multicentre, Prospective, Observational Study

  2024cites this paper
• Using data on biomarkers and siblings to study early-life economic determinants of type-2 diabetes.

  2024cites this paper
• Societal costs of sepsis in the Netherlands

  2024influential citation
• The Burden of Type 2 Diabetes on the Productivity and Economy in Sub-Saharan Africa: A Life Table Modelling Analysis from a South African Perspective

  2024cites this paper
• The Evaluation of the Glucose-Lowering Effect of Bloodletting Therapy in Type 2 Diabetes Mellitus

  2024influential citation
• The bio-artificial pancreas to treat type 1 diabetes: Perspectives from healthcare professionals in the Netherlands

  2024cites this paper
• Socioeconomic inequalities and diabetes complications: an analysis of administrative data from Hungary

  2024cites this paper
• Living with my diabetes – introducing eHealth into daily practices of patients with type 2 diabetes mellitus

  2024cites this paper
• Comparative Review of the Socioeconomic Burden of Lower Back Pain in the United States and Globally

  2024cites this paper
• Trends in economic burden of type 2 diabetes in China: Based on longitudinal claim data

  2023cites this paper
• Diet in the management of type 2 diabetes: umbrella review of systematic reviews with meta-analyses of randomised controlled trials

  2023cites this paper
• The burden of type 2 diabetes mellitus in states of the European Union and United Kingdom at the national and subnational levels: A systematic review

  2023cites this paper
• Use of hospital care among Dutch diabetes patients

  2023cites this paper
• Evaluating the Clinical and Economic Outcomes Associated with Poor Glycemic Control in People with Type 1 Diabetes in the Netherlands

  2023cites this paper
• Studying the association of diabetes and healthcare cost on distributed data from the Maastricht Study and Statistics Netherlands using a privacy-preserving federated learning infrastructure

  2022cites this paper
• A non-invasive risk score including skin autofluorescence predicts diabetes risk in the general population

  2022cites this paper
• Cost-Effectiveness of Hybrid Closed Loop Insulin Pumps Versus Multiple Daily Injections Plus Intermittently Scanned Glucose Monitoring in People With Type 1 Diabetes in The Netherlands

  2022cites this paper
• Single-Pill Combination to Improve Hypertension Treatment: Pharmaceutical Industry Development

  2022cites this paper
• Medical Devices, Smart Drug Delivery, Wearables and Technology for the treatment of Diabetes Mellitus.

  2022cites this paper
• Self-monitoring of blood glucose in patients with type 2 diabetes mellitus from the standpoint of evidence-based medicine

  2022cites this paper
• Plasma phosphate and all-cause mortality in individuals with and without type 2 diabetes: the Dutch population-based lifelines cohort study

  2022cites this paper
• Epidemiology of chronic inflammatory demyelinating polyradiculoneuropathy in The Netherlands

  2022cites this paper
• A procurement‐based classification of pharmaceutical supplies for diabetes disease management

  2022cites this paper
• The long-term cost-effectiveness of oral semaglutide in the Netherlands based on the PIONEER 2, 3 and 4 randomized controlled trials.

  2021cites this paper
• A total cost perspective of type 1 and 2 diabetes mellitus in two South African medical schemes servicing the public healthcare sector.

  2021cites this paper
• Evidence and Potential Mechanisms of Jin-Gui Shen-Qi Wan as a Treatment for Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis

  2021influential citation
• Diabetes Mellitus among Adults on Highly Active Anti-retroviral therapy and its Associated Factors in Ethiopia: Systematic review and Meta-analysis.

  2021cites this paper
• “It Is a Full-time Job to Be Ill”: Patient Work Involved in Attending Formal Diabetes Care Among Socially Vulnerable Danish Type 2 Diabetes Patients

  2021cites this paper
• A Head-To-Head Comparison of Benzbromarone and Allopurinol on the Risk of Type 2 Diabetes Mellitus in People With Asymptomatic Hyperuricemia

  2021cites this paper
• Diabetes severity measured by treatment control status and number of anti-diabetic drugs affects presenteeism among workers with type 2 diabetes

  2021cites this paper
• Effect of Huang-Lian Jie-Du Decoction on Glucose and Lipid Metabolism in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis

  2021cites this paper
• An Innovative Approach for Decision-Making on Designing Lifestyle Programs to Reduce Type 2 Diabetes on Dutch Population Level Using Dynamic Simulations

  2021cites this paper
• The burden of type 2 diabetes in Europe: current and future aspects of insulin treatment from patient and healthcare spending perspectives.

  2020cites this paper
• The cost‐effectiveness of dapagliflozin compared to DPP‐4 inhibitors in the treatment of type 2 diabetes mellitus in the Netherlands

  2020cites this paper
• A personalised screening strategy for diabetic retinopathy: a cost-effectiveness perspective

  2020cites this paper
• Metformin and statin use associate with plasma protein N-glycosylation in people with type 2 diabetes

  2020cites this paper
• Nationale Diabetes Registratie

  2020cites this paper
• The Impact of Diabetes Status on Presenteeism in Japan.

  2020cites this paper
• Burden of disease of type 2 diabetes mellitus: cost of illness and quality of life estimated using the Maastricht Study

  2020cites this paper
• Drug utilization in the Maastricht Study

  2020cites this paper
• Diabetes und Krankheitskosten

  2019cites this paper
• The financial burden of non-communicable diseases in the European Union: a systematic review.

  2019cites this paper
• Factors of occurrence and improvement methods of presenteeism attributed to diabetes: A systematic review

  2019cites this paper
• Once-weekly semaglutide for patients with type 2 diabetes: a cost-effectiveness analysis in the Netherlands

  2019cites this paper
• How much to invest in glycemic control of a patient with diabetes mellitus type 2? A constant dilemma for the Brazilian Public Health System (SUS)

  2019cites this paper
• Danshen injections protect the renal function of streptozotocin-induced diabetic rats by suppression of inflammatory factors TLR 4 and MCP-1

  2019cites this paper
• Clinical effectiveness of liraglutide vs basal insulin in a real‐world setting: Evidence of improved glycaemic and weight control in obese people with type 2 diabetes

  2018cites this paper
• Clinical efficacy of invigorating qi, nourishing yin, and promoting blood circulation in treatment of type 2 diabetes mellitus

  2018cites this paper
• Health promotion and disease prevention can substantially reduce the total economic burden of diabetes in the Netherlands.

  2017influential citation